GPLD1 and obesity disorder: In conclusion, EGCG may restore lipid metabolic homeostasis by targeting key nodes—PISD, PLD, and PTDSS—in glycerophospholipid metabolism, thereby ameliorating lipid disorders and contributing to the prevention of obesity-induced precocious puberty.